Illness Communication Avoidance
Conditions
Interventions
control group:Routine care
intervention group:illness communication avoidance intervention
Observation group:None
Sponsors
The Clinical Technology Research And Development Center of Shanghai Proton and Heavy Ion Center; Shanghai Proton and Heavy Ion Center (SPHIC)
Eligibility
Sex/Gender
All
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patient inclusion criteria: 1. Female patients aged 20 to 80 years and male patients aged 22 to 80 years (in line with the legal marriageable age in China); 2. Diagnosed with HNC by pathology, including primary tumors in the oral cavity, nasal cavity, pharynx, maxillofacial region, salivary glands, and neck; 3. Undergoing radiotherapy with or without concurrent chemotherapy, with a total radiotherapy dose ranging from 40 to 75 Gy (5 fractions per week), and treatment duration of 4 to 7 weeks; 4. Married, and the main caregiver during hospitalization is the spouse; 5. Able to listen, speak, read, write, and correctly understand and answer questions; 6. Informed of the tumor diagnosis, willing to participate in this study and sign the informed consent form. Spouse inclusion criteria: 1. Spouses of HNC radiotherapy patients included in this study; 2. Main caregivers; 3. Good listening, speaking, reading, writing, and communication skills; 4. Informed consent and willingness to participate in the study.
Exclusion criteria
Exclusion criteria: Patient exclusion criteria: 1. In the acute stage of the disease, or with severe liver and kidney function, heart and lung function impairment reaching grade III or above (according to CTCAE v5.0 standards); 2. Diagnosed with severe mental disorders (such as schizophrenia, severe depression with psychotic symptoms, etc.), or with significant cognitive function deficits (such as a Montreal Cognitive Assessment (MoCA) score below 20 points). Spouse exclusion criteria: 1. Cognitive impairment; 2. Life-threatening diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| illness communication avoidance; | — |
Secondary
| Measure | Time frame |
|---|---|
| intimacy;Adherence to the disease communication avoidance intervention.;dyadic coping;quality of life; | — |
Countries
China
Contacts
Public ContactHongwei Wan
The Clinical Technology Research And Development Center of Shanghai Proton and Heavy Ion Center; Shanghai Proton and Heavy Ion Center (SPHIC)
Outcome results
None listed